Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease.
about
PNPLA3 mediates hepatocyte triacylglycerol remodelingStudying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiologyPediatric fatty liver disease: role of ethnicity and geneticsDefinitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic ReviewLiver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicineThe PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulationAdiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase.Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease.PNPLA3/adiponutrin functions in lipid droplet formation.Pediatric non-alcoholic fatty liver disease: New insights and future directionsThe Association between Pediatric NAFLD and Common Genetic Variants.Mechanisms of Liver Injury in Non-Alcoholic SteatohepatitisHepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intakePnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosisThe rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta-analysisInfluence of the PNPLA3 rs738409 Polymorphism on Non-Alcoholic Fatty Liver Disease and Renal Function among Normal Weight Subjects.PNPLA3 genetic variation in alcoholic steatosis and liver disease progression.Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescentsFAT SIGNALS--lipases and lipolysis in lipid metabolism and signaling.Nonalcoholic fatty liver disease induced by noncanonical Wnt and its rescue by Wnt3aLinked PNPLA3 polymorphisms confer susceptibility to nonalcoholic steatohepatitis and decreased viral load in chronic hepatitis B.PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity.Fasting-induced G0/G1 switch gene 2 and FGF21 expression in the liver are under regulation of adipose tissue derived fatty acids.Calcium-independent phospholipases A2 and their roles in biological processes and diseases.DAG tales: the multiple faces of diacylglycerol--stereochemistry, metabolism, and signalingOxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis.The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH).PNPLA3 polymorphisms and liver aminotransferase levels in a Mexican American populationChronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease.Role of patatin-like phospholipase domain-containing 3 on lipid-induced hepatic steatosis and insulin resistance in ratsBiochemistry and pathophysiology of intravascular and intracellular lipolysis.Genetic signatures in choline and 1-carbon metabolism are associated with the severity of hepatic steatosisThe MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent.Overexpression of variant PNPLA3 gene at I148M position causes malignant transformation of hepatocytes via IL-6-JAK2/STAT3 pathway in low dose free fatty acid exposure: a laboratory investigation in vitro and in vivo.PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Non-alcoholic Fatty Liver Disease (NAFLD) in a Chinese Population.Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent.The PNPLA3 Ile148Met interacts with overweight and dietary intakes on fasting triglyceride levelsGenetic-related and carbohydrate-related factors affecting liver fat accumulation.
P2860
Q24336530-7BBC43BB-705A-4828-BD39-8D30F80DFA2CQ27010291-65BC8959-5D0B-40C8-81CF-1ED7A92B51BCQ27026295-E392EEC3-E803-42D2-AAB3-DCC60AFEAC14Q28070408-B5E20D67-B77B-441E-A359-3741128B87CAQ28086887-A19ED483-D837-4A3E-9C66-D239C78A9250Q28727506-9A3CFFBD-B3F5-474E-B5EF-34DEB137923EQ30032295-C138341D-769A-4C8A-98A9-6C0766F4F9E0Q30244335-AD5D79A0-CBEC-495C-A862-6F1F28C00C6DQ32872131-0AFAA48C-F523-4DA2-93FB-585411E99892Q33563887-039B4F30-FCE9-4537-BE3F-131EEDF80BB9Q33831722-FA82DD88-3862-439C-8208-D803A3DFB2E4Q33898945-03397ADD-7151-46CD-93A0-BE292FA32346Q34282151-4B5BE140-EC07-4E2D-A08B-0A081B5C7FB4Q34675058-8D44C820-187C-45B3-B1B8-76A149A0C969Q34757399-6A64073A-FDF9-44C0-B2A5-0A7C4582AF02Q35704998-A2B27F0F-5173-4D19-B902-5E1AAE9FCF7EQ35737438-350D5CC9-994E-4175-A3B9-E747D710DEA8Q35783993-B2389191-2727-4A7B-B054-5DCE3660317DQ35859576-D755DB02-C35F-43F2-90D6-4ED9DC5A8082Q35878960-1786608A-B9FD-4EB9-B423-303317E5DC45Q35891405-6523F900-961B-4395-A5DE-789FF5C92846Q35894263-6C877D55-23B2-4C75-A32D-9E1A0B530CD0Q35899007-AC11B340-4A0D-462B-B108-474B7DF6003AQ35994344-6E4E826D-7A9D-4004-9CB6-42446CFFEC99Q36074560-15E1A670-ABF3-4498-84CF-451C12245929Q36083096-F0EAB315-173D-4BD6-ACAF-FB0AEF3B0003Q36123336-5530233D-0237-4A2E-B5A6-24B8800FB902Q36231508-1507CF3D-DAAB-4815-BFFA-91C2D66F4C9AQ36357941-7CD530A6-FC98-4AE1-AE49-C3C3283324B1Q36395336-C9550AE0-EFC0-4BC1-885A-540A357417E2Q36684364-392A2421-07A3-4F4E-89D5-93B59356CBA2Q36708030-3D7946BF-C155-4D62-8886-8662439AA4C6Q36710902-A15B5E16-2CA4-4361-9C04-A34159AE847BQ36833028-B5A986C1-4E12-4743-A716-1D7717133690Q36878525-407E6194-4261-46DF-97CD-EA11771BE523Q36973400-C28A5EE9-A9E4-47B0-B036-FCDA86ABFF56Q37143687-9C3F3B83-B3DB-44A3-BB47-402DFCC7A49AQ37197345-DCA04436-CF25-4502-8816-633C953672B2Q37669834-EC63354C-E63A-483C-844E-75CF5E6F10BBQ38012269-AFCC7A12-6678-4484-B13A-5DEB614499EC
P2860
Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Expression and characterizatio ...... alcoholic fatty liver disease.
@ast
Expression and characterizatio ...... alcoholic fatty liver disease.
@en
type
label
Expression and characterizatio ...... alcoholic fatty liver disease.
@ast
Expression and characterizatio ...... alcoholic fatty liver disease.
@en
prefLabel
Expression and characterizatio ...... alcoholic fatty liver disease.
@ast
Expression and characterizatio ...... alcoholic fatty liver disease.
@en
P2093
P2860
P356
P1476
Expression and characterizatio ...... alcoholic fatty liver disease.
@en
P2093
Helen H Hobbs
Jonathan C Cohen
Yongcheng Huang
P2860
P304
37085-37093
P356
10.1074/JBC.M111.290114
P407
P577
2011-08-30T00:00:00Z